摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-dihydro-8-hydroxy-5-oxo-2,6-naphthyridine-7-carboxylic acid ethyl ester | 1147284-45-4

中文名称
——
中文别名
——
英文名称
5,6-dihydro-8-hydroxy-5-oxo-2,6-naphthyridine-7-carboxylic acid ethyl ester
英文别名
ethyl 4-hydroxy-1-oxo-2H-2,6-naphthyridine-3-carboxylate
5,6-dihydro-8-hydroxy-5-oxo-2,6-naphthyridine-7-carboxylic acid ethyl ester化学式
CAS
1147284-45-4
化学式
C11H10N2O4
mdl
——
分子量
234.211
InChiKey
JIHCLKHBWKUGCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    88.5
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dion-2-acetic acid ethyl ester 在 乙醇sodium ethanolate溶剂黄146 作用下, 以 乙醇 为溶剂, 反应 0.5h, 以35%的产率得到5,6-dihydro-8-hydroxy-5-oxo-2,6-naphthyridine-7-carboxylic acid ethyl ester
    参考文献:
    名称:
    Synthesis and spectroscopic properties of novel polyfunctionally substituted 2,6- and 2,7-naphthyridines
    摘要:
    Series of 5,6-dihydro-8-hydroxy-5-oxo-2,6-naphthyridine-7-carboxylic acid derivatives (2,4) and the isomeric 7,8-dihydro-5-hydroxy-8-oxo-2,7-naphthyridine-6-carboxylic acid derivatives (3,5) having potential pharmacological activity were synthesized from 3,4-pyridinedicarboxylic acid derivatives. Spectroscopic data (IR, H-1- and C-13-NMR, MS) are analyzed and support the enol-lactam structure of compounds 2-5 in Solution, solid state and gas phase. Results in the different series (2.6- vs 2,7-naphthyridines and N-unsubstituted lactam vs N-methyl derivatives) are compared. and common and differential features amongst them are indicated. (C) 2009 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.molstruc.2009.01.012
点击查看最新优质反应信息

文献信息

  • HCV NS3 PROTEASE INHIBITORS
    申请人:MERCK SHARP & DOHME CORP.
    公开号:US20140296136A1
    公开(公告)日:2014-10-02
    The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
    本发明涉及公式(I)的大环化合物,它们是丙型肝炎病毒(HCV)NS3蛋白酶抑制剂,它们的合成以及它们用于治疗或预防HCV感染的用途。
  • US9328138B2
    申请人:——
    公开号:US9328138B2
    公开(公告)日:2016-05-03
查看更多